Clinical Trial: A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in Adults

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766655) titled 'A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in Adults' on Aug. 11.

Brief Summary: This study is a Phase 3, multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group trial to evaluate the efficacy and safety of AXS-05 compared to placebo and bupropion for smoking cessation in adults.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Smoking Cessation

Intervention: DRUG: AXS-05 (dextromethorphan-bupropion)

AXS-05 tablets, taken twice daily for 12 weeks.

DRUG: Bupropion

Bupropion tablets, taken twice daily for 12 weeks.

DRUG: Placebo

Placebo tablets...